Christopher K Mirabelli

This inventor holds 21 USPTO granted patents, primarily in Oligonucleotide Therapies. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 1993-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher K Mirabelli. Retrieved from https://idiyas.com/inventor/christopher-k-mirabelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21

% Patents Active = 95.2

Average Co-Inventor Count = 2.9

ph-index = 10

Forward Citations = 648(Granted Patents)

Location History:

Encinitas, CA (US) (1993 - 2001)
Dover, MA (US) (1997 - 2005)

Company Filing History:

21 out of 1,035

Isis Pharmaceuticals, Inc.

patents

Years Active: 1993-2005

Loading Chart...

Areas of Expertise:

Oligonucleotide

Cell Adhesion

Papillomavirus

Antisense

Herpesviruses

Drug Modulation

Gene Therapy

Virus Inhibition

Arachidonic Acid

Therapeutics

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6849612 - Oligonucleotide modulation of cell adhesion (2005-02-01),

2. 6310044 - Oligonucleotide therapies for modulating the effects of herpesviruses (2001-10-30),

3. 6300491 - Oligonucleotide inhibition of cell adhesion (2001-10-09),

4. 6174870 - Antisense oligonucleotide inhibition of papillomavirus (2001-01-16),

5. 6169079 - Oligonucleotide inhibition of cell adhesion (2001-01-02),

6. 6096722 - Antisense modulation of cell adhesion molecule expression and treatment (2000-08-01),

7. 6093811 - Oligonucleotide modulation of cell adhesion (2000-07-25),

8. 6015894 - Oligonucleotide modulation of cell adhesion (2000-01-18),

9. 5843738 - Oligonucleotide modulation of cell adhesion (1998-12-01),

10. 5811232 - Oligonucleotides for Papillomavirus (1998-09-22),

11. 5756282 - Oligonucleotides for the diagnosis of papillomavirus (1998-05-26),

12. 5681944 - Antisense oligonucleotides directed to papillomavirus (1997-10-28),

13. 5665580 - Antisense oligonucleotide inhibition of papillomavirus transformed cells (1997-09-09),

14. 5658891 - Oligonucleotide therapies for modulating the effects of herpesviruses (1997-08-19),

15. 5639595 - Identification of novel drugs and reagents (1997-06-17),

Title: The Innovative Journey of Christopher K Mirabelli

Introduction: Christopher K Mirabelli, a talented inventor hailing from Dover, MA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Christopher K Mirabelli holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Christopher K Mirabelli has worked for renowned tech companies, leading research institutions, and universities, where he has spearheaded numerous projects that have pushed the boundaries of innovation.

Collaborations: Throughout his career, Christopher K Mirabelli has collaborated with top-notch engineers, scientists, and researchers, fostering a culture of innovation and excellence in every project he undertakes.

Conclusion: Christopher K Mirabelli's passion for innovation, coupled with his relentless drive to solve complex problems, has solidified his position as a pioneering inventor in the tech industry, leaving a lasting impact on future generations of inventors to come.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]